News for 'Sun Pharmaceuticals'

'We couldn't imagine this 15 years ago'

'We couldn't imagine this 15 years ago'

Rediff.com16 Jun 2023

'At the heart of the strategic relationship between our countries are economic ties.'

Medical devices industry eyes Rs 70,000 cr investment in 5 years

Medical devices industry eyes Rs 70,000 cr investment in 5 years

Rediff.com24 May 2020

The government is targeting 1,200 technical collaborations between Japanese companies and Indian investors for over Rs 42,000 crore, 200 joint ventures with overseas investors for Rs 14,000 crore, and another Rs 14,000-crore investment from about 50 multinational companies.

'Worse for heart attacks': British Indian doc flags issues with Covishield

'Worse for heart attacks': British Indian doc flags issues with Covishield

Rediff.com7 Feb 2023

Dr Malhotra, who has demanded a full safety review into the use of AstraZeneca's Covid vaccine, told PTI Covishield "should never have been rolled out in the country in the first place".

Covid fears in China may have cascading impact on India's exports, imports

Covid fears in China may have cascading impact on India's exports, imports

Rediff.com30 Dec 2022

The importance of China as India's top trading partner cannot be understated.

Checks On Drug-Making Units Begins

Checks On Drug-Making Units Begins

Rediff.com29 Dec 2022

The joint inspections is to ensure the safety, efficacy, and quality of drugs available in the country

Ex-Ranji cricketer held for trying to dupe Hyd businessman

Ex-Ranji cricketer held for trying to dupe Hyd businessman

Rediff.com17 Nov 2020

Nagaraju (25), was previously arrested in seven cases in Telangana and Andhra Pradesh, it said, adding he is a native of Srikakulam District in Andhra Pradesh.

How Stock Market has Changed in 40 Years

How Stock Market has Changed in 40 Years

Rediff.com13 Jul 2021

While Nifty 50 reflects changes in 40 years, it also shows what is missing: Low-cost manufacturers at one end, and deep-value players at the other. Also missing are technology players, observes T N Ninan.

Lupin recalls 5.61 lakh pouches of India-made birth control pills in US

Lupin recalls 5.61 lakh pouches of India-made birth control pills in US

Rediff.com21 Aug 2020

Baltimore-based Lupin Pharmaceuticals Inc is recalling 5,60,922 pouches of Mibelas 24 Fe (norethindrone acetate and Ethinyl estradiol tablets and ferrous fumarate tablets) in the US, as per the latest enforcement report by the USFDA.

4 Indian drug firms recall products in US market

4 Indian drug firms recall products in US market

Rediff.com15 Nov 2020

Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the US Food and Drug Administration (USFDA). While Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid. Similarly, Aurobindo Pharma (USA) is recalling pain relieving drug, while Jubilant Cadista is recalling a medication used to treat schizophrenia.

Glenmark to conduct trials of potential COVID-19 drug

Glenmark to conduct trials of potential COVID-19 drug

Rediff.com30 Apr 2020

As per the clinical trial protocol approved, 150 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1 ratio to Favipiravir with standard supportive care or standalone standard supportive care. Treatment duration is a maximum of 14 days and the total study duration will be a maximum for 28 days from randomisation.

After cement, Adani to foray into healthcare

After cement, Adani to foray into healthcare

Rediff.com19 May 2022

Billionaire Gautam Adani's group has created a new company for its foray into healthcare services through the acquisition of large hospitals, diagnostic chains, and offline and digital pharmacies. Adani Enterprises Ltd - the group's business incubator firm - in a regulatory filing said a wholly-owned subsidiary, Adani Health Ventures Ltd (AHVL) was incorporated on May 17, 2022. AVHL will "carry on the business of healthcare-related activities including, inter alia, setting up, running, administrating medical and diagnostic facilities, health aids, health tech-based facilities, research centers and to do all other allied and incidental activities in this regard," it said.

Investors poorer by over Rs 4.65 lakh cr as markets go into tailspin

Investors poorer by over Rs 4.65 lakh cr as markets go into tailspin

Rediff.com17 Dec 2021

Investors' wealth on Friday tumbled by over Rs 4.65 lakh crore as markets suffered a heavy selloff following weak global trends and continued selling by foreign institutional investors. The 30-share BSE benchmark Sensex plunged 889.40 points or 1.54 per cent to close at 57,011.74. During the day, it tumbled 950.16 points to 56,950.98. The market capitalisation of BSE-listed companies declined by Rs 465,570.82 crore to Rs 2,59,37,277.66 crore amid weak sentiments.

Want To Know What A CEO/MD Earns?

Want To Know What A CEO/MD Earns?

Rediff.com28 Dec 2022

The average top executive monthly compensation is Rs 1 crore. The median employee salary is now Rs 820,000.

'Profiting from Pain': Covid created new billionaire every 30 hrs

'Profiting from Pain': Covid created new billionaire every 30 hrs

Rediff.com23 May 2022

Releasing a report titled 'Profiting from Pain' in Davos, the rights group further said as the cost of essential goods rises faster than it has in decades, billionaires in the food and energy sectors are increasing their fortunes by $1 billion every two days.

Manufacturing sector companies outperform on the bourses in 2022

Manufacturing sector companies outperform on the bourses in 2022

Rediff.com27 Dec 2022

Manufacturing companies have been outperformers on the bourses in the current year, leading to a rise in their weighting in the benchmark index. Companies in sectors such as FMCG, automobile, pharmaceuticals, metals, cement, and agrochemicals now account for 25.43 per cent of the Nifty 50 index, up 88 basis points from 24.55 per cent at the end of December last year and a record low of 23.1 per cent at the end of CY20. The manufacturing sector is now dominated by FMCG majors such as Hindustan Unilever, ITC, Asian Paints, Nestle, and Britannia, accounting for 45 per cent of the combined market cap of all manufacturing companies in the index.

Ashoka University founders step down from board after CBI probe

Ashoka University founders step down from board after CBI probe

Rediff.com7 Jan 2022

Ashoka University co-founders Vineet Gupta and Pranav Gupta, who were booked last week by the Central Bureau of Investigation in a Rs 1,600 crore fraud case, on Thursday stepped down from all boards and committees of the varsity.

PIX: Gadkari rides to Parliament in hydrogen-powered car

PIX: Gadkari rides to Parliament in hydrogen-powered car

Rediff.com30 Mar 2022

India will soon become a green hydrogen exporting country, the road transport and highways minister told reporters before leaving for Parliament in the car, which is the first of its kind in India.

Why India Inc is moving to Dubai in droves

Why India Inc is moving to Dubai in droves

Rediff.com7 Nov 2022

Reliance Industries chairman Mukesh Ambani might have made news for purchasing the most expensive beach-side villa in Dubai recently, but he is not the only Indian eyeing the city for investment. Since Dubai allowed foreign investors full ownership in specific sectors in June 2021, a horde of Indian companies have moved or expanded into the desert city. The list even includes a kindergarten, an elementary and middle school, and a hotel that has sought 100 per cent ownership.

Centre advises use of mask in crowded areas amid fresh Covid scare

Centre advises use of mask in crowded areas amid fresh Covid scare

Rediff.com21 Dec 2022

He urged people not to panic and clarified that there was no change in the guidelines for international air travel so far.

Hiring to grow by 7% in Apr-June if further lockdowns not imposed

Hiring to grow by 7% in Apr-June if further lockdowns not imposed

Rediff.com14 Apr 2021

The intent to hire in the current quarter is likely to rise by 7 per cent over the previous three months if further lockdowns and workplace operating rules are not enforced, mainly driven by demand in healthcare, pharmaceuticals, educational services, ecommerce and technology start-ups and IT, according to a report. In fact, out of the 21 sectors reviewed, more than 8 sectors will witness a 9-11 per cent rise in their intent to hire in the current quarter, TeamLease Employment Outlook Report has revealed.

Exports rise 16.78%; trade deficit at record $25.63 bn

Exports rise 16.78%; trade deficit at record $25.63 bn

Rediff.com4 Jul 2022

India's merchandise exports in June rose by 16.78 per cent year-on-year to $37.94 billion while the trade deficit ballooned to a record $25.63 billion on account of a steep increase in gold and crude oil imports, according to the government's preliminary data released on Monday. The export growth in June moderated from 20.55 per cent in May and 48.34 per cent in June 2021. During the month under review, exports of engineering, pharmaceutical and plastic products recorded negative growth.

India pushes for rupee trade with Cuba

India pushes for rupee trade with Cuba

Rediff.com20 Sep 2022

The Centre is pushing for bilateral trade with Cuba and its settlement in rupee as a part of its strategy to internationalise the domestic currency. A delegation from Cuba, including officials from its central bank, met Indian government officials and banks last month to discuss bilateral trade and settlement using the Reserve Bank of India's (RBI's) payment mechanism in rupee, said people aware of the matter. Since the Cuban nation has opened up its economy and is looking to implement reforms to attract investments from India, Cuban banks have evinced interest in opening special rupee vostro accounts (SRVAs) with Indian banks.

COVID-19: Russian flights with humanitarian aid land in India

COVID-19: Russian flights with humanitarian aid land in India

Rediff.com29 Apr 2021

Two Russian flights with oxygen concentrators, lung ventilation equipment, bedside monitors, medicines, including Coronavir and other essential pharmaceutical items landed in India to help the country in its fight against the COVID-19 surge.

'We are exploring setting up an aerotropolis'

'We are exploring setting up an aerotropolis'

Rediff.com10 Mar 2023

'We would like to develop Andhra Pradesh into a logistics hub not only for India, but also for South Asia.'

Covid to grip the world, kill millions in next 90 days: Epidemiologist

Covid to grip the world, kill millions in next 90 days: Epidemiologist

Rediff.com20 Dec 2022

The epidemiologist estimates that more than 60 per cent of China and 10 per cent of Earth's population are likely to be infected over the next 90 days with deaths likely in the millions.

Cipla gets nod to import Moderna vaccine for emergency use in India

Cipla gets nod to import Moderna vaccine for emergency use in India

Rediff.com29 Jun 2021

India's drug regulator Drugs Controller General of India has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, official sources said on Tuesday.

Govt to settle almost all retro-tax cases this month

Govt to settle almost all retro-tax cases this month

Rediff.com4 Feb 2022

The government will settle almost all the retrospective tax cases this month, closing a chapter that plagued India's reputation as an investment-friendly destination, a top official said on Friday. A 2012 amendment that gave taxmen powers to go back 50 years and slap capital gains levies wherever ownership had changed hands overseas but business assets were in India, was used to raise Rs 1.1 lakh crore demand against multi-nationals such as telecom group Vodafone, pharmaceuticals company Sanofi and brewer SABMiller, now owned by AB InBev, and Cairn Energy Plc. Such demands brought uncertainty in the minds of investors.

Drug to treat mild, moderate COVID-19 launched in India

Drug to treat mild, moderate COVID-19 launched in India

Rediff.com20 Jun 2020

FabiFlu is the first oral favipiravir-approved medication in India for the treatment of COVID-19. Favipiravir can be used for coronavirus patients with co-morbid conditions such as diabetes and heart disease with mild to moderate COVID-19 symptoms.

Kashmir University PhD scholar held for seditious magazine article

Kashmir University PhD scholar held for seditious magazine article

Rediff.com17 Apr 2022

Abdul Aala Fazili was arrested from his Humhama residence as the SIA conducted searches at several locations in the city as part of its crackdown on terror and anti-national networks, the official said.

Market correction insufficient and pressure to continue, says Nomura

Market correction insufficient and pressure to continue, says Nomura

Rediff.com10 Jun 2022

The correction seen in the stock markets thus far is insufficient and there are significant downside risks, given the way macroeconomic data is shaping up, a Nomura equity strategist said on Thursday. "The markets are trying to look through the current stress we see in the macros. There are potential risks to the market. "Our estimates assume no major impact on growth and earnings. "The market should have been at least 5 per cent lower than it is now.

'Markets may remain sideways'

'Markets may remain sideways'

Rediff.com29 Aug 2022

'The idea is to invest where there is opportunity.'

7 Foods Diabetics Should Avoid

7 Foods Diabetics Should Avoid

Rediff.com14 Nov 2022

Starting your day with breakfast cereals or granola bars is something diabetic patients should totally avoid.

Current Covid wave may lead to new variants, warn Chinese health experts

Current Covid wave may lead to new variants, warn Chinese health experts

Rediff.com21 Dec 2022

Wang Guangfa, a respiratory expert from Peking University First Hospital, warned that Beijing may experience a spike in severe COVID-19 cases over the next fortnight.

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Rediff.com12 Feb 2020

Indian pharmaceutical companies are heavily dependent on China to source fermentation-based active pharmaceutical ingredients and intermediates to manufacture these medicines, but the coronavirus outbreak there has disrupted the supply.

IIT-Madras is India's Top University

IIT-Madras is India's Top University

Rediff.com15 Jul 2022

Seven Indian Institutes of Technology -- IIT-Madras, IIT-Bombay, IIT-Delhi, IIT-Kanpur, IIT-Kharagpur, IIT-Roorkee and IIT-Guwahati -- figured in the top 10 in the overall rankings.

At $4.3 bn, imports from Russia jump nearly 7 times in June

At $4.3 bn, imports from Russia jump nearly 7 times in June

Rediff.com20 Aug 2022

India imported goods worth $4.23 billion in June from sanctions-hit Russia, up 6.8 times as compared to last year, as demand for shipments of crude oil grew at the fastest pace during the month. Crude oil worth $3.02 billion was imported in June, which translates into a share of 71 per cent of the total imports from Russia, commerce and industry ministry data showed. Similarly, during the April-June quarter, India's imports from Russia were valued at $9.27 billion, up 369 per cent on year.

GST Council likely to meet early Jan; may discuss rate rationalisation

GST Council likely to meet early Jan; may discuss rate rationalisation

Rediff.com20 Dec 2021

The Centre is looking to convene a meeting of the all-powerful Goods and Service Tax Council in early January. The meeting is likely to focus on rectifying the inverted duty structure for a few more items and will also serve as a platform for pre-Budget discussions between Union Finance Minister Nirmala Sitharaman and state finance ministers, Business Standard has learnt. "The current Winter Session of Parliament ends on December 23, followed by the Christmas-New Year period. "After that we would like to have a meeting of the GST Council, depending on whether there can be a quorum," a top government official said.

Exports up 22.36%; trade deficit widens to $21.19 bn in Feb

Exports up 22.36%; trade deficit widens to $21.19 bn in Feb

Rediff.com2 Mar 2022

India's exports rose by 22.36 per cent to $33.81 billion in February on account of healthy growth in sectors like engineering, petroleum and chemicals, even as the trade deficit widened to $21.19 billion, according to preliminary data released by the commerce ministry on Wednesday. Imports during the month too jumped by about 35 per cent to $55 billion, with inbound shipments of petroleum and crude oil surging 66.56 per cent to $15 billion. The trade deficit -- the difference between imports and exports -- stood at $13.12 billion in February 2021.

Govt waives import duty on Remdesivir

Govt waives import duty on Remdesivir

Rediff.com20 Apr 2021

This import duty exemption would remain in force till October 31 this year.

Amid Covid surge, govt approves ramping up remdesivir production

Amid Covid surge, govt approves ramping up remdesivir production

Rediff.com14 Apr 2021

The current total installed capacity of the seven manufacturers of remdesivir is 38.80 lakh vials per month, the Ministry of Chemicals and Fertilizers said in a statement.